Drug Screening Market to boost ,447 Million by 2023

Posted by Sanket Solanki on February 26th, 2019

Drug screening test analyses biological samples, such as blood, hair, & urine; to diagnose the presence of drug abuse or its metabolites in patient’s body. Drug screening tests are used to determine if person is or was under the influences of drug at a certain point of time.

Global Drug Screening Market is expected to reach ,447 million in 2023 from ,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 2017- 2023.                                         

Drug screening devices have improved owing to introduction of new technology; offering the users precise and accurate results. Rise in alcohol consumption among youth as well as elderly population, overuse of prescribed drugs, increase in use of narcotics and illicit drugs is a major driver for the market.

Download Sample of the Report @ https://www.alliedmarketresearch.com/request-sample/1070   

The global drug screening industry is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the market is divided into immunoassay analyzers, chromatography instruments, breath analyzers, breath analyzers, rapid testing devices, and urine testing devices. The breath analyzers are further classified into fuel cell breath analyzers, semiconductor breath analyzers, and other devices. The RTD (rapid testing devices) is bifurcated into urine testing devices and oral fluid/saliva testing devices. The urine testing devices are further classified into urine testing cups, dip cards and cassettes Based on consumables assay kits, sample collection cups, calibrators & controls, and other consumables.

Laboratory services hold major market share in this segment. The sample type segment is divided into urine sample, breath sample, oral fluid sample, hair sample, and other sample (blood & sweat). Urines sample are widely used and draw a large amount of share in this segment. Based on end user, the industry is divided into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, drug treatment centers, pain management centers, and personal users.

Key Findings of the Drug Screening Market:

•              Under products & services equipment segment the rapid testing devices segment is projected to grow at the highest CAGR of 9.6% from 2017-2023 over the forecast period.
•              Hair sample segment is poised to witness the fastest growth during the forecast period.
•              Workplace and schools generated the highest revenue in 2016, and is expected to continue its dominance over the forecast period.
•              North America dominated the global drug screening market over the analysis period, and is projected to grow at a CAGR of 8.1% from 2017-2023.
•              Asia-Pacific drug screening market is an upcoming market and expected to generate new opportunities for market players.

The major companies in drug screening market include Alere, Inc., Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and Express Diagnostics International Inc.